Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application-Reference-Cited by-同舟云学术

Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: A possible mechanism and the potential for clinical application

Published:2012-11 Issue:1-2 Volume:438 Page:176-183
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Abu Lila Amr S.,Eldin Noha Essam,Ichihara Masako,Ishida Tatsuhiro,Kiwada Hiroshi

Funder

Ministry of Education, Culture, Sports, Science and Technology, Japan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model;Abu-Lila;J. Control. Release,2009

2. Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor;Abu Lila;J. Control. Release,2010

3. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model;Abu Lila;J. Control. Release,2009

4. Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009;Adam;Ann. Oncol.,2010

5. Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol);Allen;Biosci. Rep.,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The interplay between PEGylated nanoparticles and blood immune system;Advanced Drug Delivery Reviews;2023-09

2. PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective;Bioconjugate Chemistry;2023-05-10

3. Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy;Cancer Nanotechnology;2023-03-07

4. Nanocarrier System for Increasing the Therapeutic Efficacy of Oxaliplatin;Current Cancer Drug Targets;2022-05

5. The Challenge to Deliver Oxaliplatin (l-OHP) to Solid Tumors: Development of Liposomal l-OHP Formulations;Chemical and Pharmaceutical Bulletin;2022-05-01